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Abstract
In an article in this Journal, Mendlovic and colleagues report on regional variation in medical care across Israeli
regions. This study joins a growing literature demonstrating generally high variation in the provision of health
care services within developed countries. This commentary summarizes the status of medical care epidemiology
and its studies of unwarranted variation in health care, and provides a conceptual framework to guide future
studies. Recommendations are offered for advancing studies in Israel that could guide policy development and
clinical improvement.
Background
If we want to improve health care, systematic population-
based measurement of health care delivery is essential
[1]. While the importance of ascertaining population
health status is well recognized, medical care as a focus
of measurement is less developed. Barriers include poor
data availability and the reluctance to publicly report
findings, resulting in a failure to identify many oppor-
tunities for policy development and clinical improve-
ment. While there are a few countries in which medical
care epidemiology is robust, the implementation of this
essential partner to disease epidemiology remains un-
even [2]. Researchers outside the U.S., U.K., and Canada
have been relatively slow in initiating analysis of medical
care and its variation until a decade ago, when academic
and governmental interest began to grow. One example
of greater national interest is Israel’s participation in the
medical practice variation project of the Organisation
for Economic Co-operation and Development (OECD)
[3] which led to Mendlovic and colleagues’ recent paper
in IJHPR [4]. This article reports an important study for
the Israeli health care system and makes a notable con-
tribution to the international effort to better understand
health care and target improvement.
The landscape of Israeli hospital utilization shows
striking similarities, and some differences, to the other
12 countries participating in the OECD project [3]. With
two exceptions, regional variation of medical hospitaliza-
tions and procedures was markedly high, a phenomenon
observed for most types of medical and surgical care
wherever measured [5]. Low variation in utilization was
found for surgery after hip fracture in Israel as has also
been observed in other developed countries. This can be
attribiuted to professional certainty in diagnosis and the
need for treatment. Almost all hip fractures are diag-
nosed and have surgery. Therefore, hip fracture with sur-
gery rates correlate closely with disease incidence. In
general, differences in populations, including health sta-
tus, are less important contributors to variation than is
professional uncertainty and physician practice styles.
More unusual was Israel’s low variation in hysterecto-
mies, but Israel also has the lowest rate of hysterecto-
mies of the 13 reporting OECD countries. To place
Israel’s rate of 122 hysterectomies per 100,000 in per-
spective, Spain had the next highest rate at 172, and
Canada’s rate was 394, the highest of the 13 participating
countries.
Development of medical care epidemiology
Description is the start of any epidemiologic analysis,
and quickly leads to questions of causation. What factors
lead to high medical practice variation? Can we say that
some types of medical practice variation are “good” and
other types “bad?” If we determine the causes, are there
remedies that might improve health care and health? At
this early stage, there are no specific answers to these
questions for Israel. Inferential analysis of the causes and
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health consequences of variation proceeds much more
slowly than description. But there is a sizable body of
inferential research from other countries that may have
relevance to Israel [5].
The primary motivation to study patterns of health
care utilization is to gain insight into the performance of
health care providers and systems. Suboptimal health
care performance has consequences for population
health, but variation in health care is only partially
explained by area population differences. The technical
term for the variation that is not explained by patient
needs or preferences is “unwarranted variation” and
reflects differences in health care quality and efficiency.
Originally, analyses examining unwarranted variation
were termed “small area analysis,” [6] in reference to
analysis across empirically defined health care service
areas (i.e. geographic health care markets). With im-
provements in data quality, recent efforts have been di-
rected toward the measurement across providers, such
as hospitals. Regardless of the units that define the
population or patient denominators, the study of health
care variation faces similar challenges in methods and
interpretation.
While the first study of medical practice variation
was published in England in 1938, [7] John Wennberg’s
1973 paper in Science reporting differences in health
care resources and utilization across the relatively
homogenous State of Vermont marked the beginning of
rapid growth in small area analysis studies in the U.S.
[8]. Given today’s recognition of the uneven shortcom-
ings in health care, it may be difficult to appreciate that
in the 1970s these findings were initially ignored, later
attacked, [9] before being replicated [10–12] and then
widely embraced by clinicians, health system adminis-
trators and policy makers in the U.S. Canada, and the
U.K. A notable testament to the seminal character of
Wennberg’s paper is its citation by over 1200 other
academic papers [13]. Subsequent studies by Dr.
Wennberg and his Dartmouth colleagues further ad-
vanced the methods to interpret regional patterns of
care from the beginning to the end of life [14, 15].
Cohort studies were developed to address inherent
weaknesses in cross-sectional designs, and ecologic
analyses were supplanted by multi-level models with
the patient as the unit of analysis [16–18]. With fund-
ing from the Robert Wood Johnson Foundation in 1992,
Wennberg and colleagues introduced the Dartmouth
Atlas of Health Care series (see www.dartmouthatlas.org)
as a dissemination tool directed towards non-academic
audiences, such as health care administrators, health
policy makers, and congressional staffers. At the same
time, research into health care variation grew in the
U.K. and Canada, and more recently, with strong sup-
port from national and provincial health ministries
[5]. In the past 40 years, these and other studies of
unwarranted variation have influenced the practice of
medicine, the organization of delivery systems, the
financing of medical care, and national health care
policy.
Types of variation
The most widely used framework for interpreting med-
ical practice variation parses unwarranted variation into
three categories—effective, preference sensitive, and sup-
ply sensitive care.
Variation in effective care
Variation in effective care reflects differences in tech-
nical quality, where medical care interventions have high
benefit and low risk. Usually, the “right” rate is close to
100% for the target population. Obvious examples are
childhood immunizations, the use of beta blockers and
aspirin in myocardial infarctions, and monitoring HgA1C
in diabetics. Low utilization rates indicate unwarranted
variation in the provision of effective medical practice.
Reducing variation in effective care is the most common
focus of clinical quality improvement efforts in Israel [19]
and internationally. Technical assistance in improving
effective care is available from the Institute for Health
Care Improvement or the International Society for Quality
in Healthcare [20, 21].
Variation in preference-based care
Preference-based care refers to utilization variation for
decisions where there are more than one diagnostic and
therapeutic option, each with its own profile of benefits
and harm. The original analyses that led to this concept
were studies of the treatment of benign prostatic hyper-
trophy in adult men [22]. In the early 1980s, the high
regional variation in the use of transurethral prostatecto-
mies in the U.S. was driven by local differences in theories
of benefit and harm held by urologists. Patients usually
followed their physician recommendations, which differed
across urologists. The risk/benefit profile of TURP
compared to watchful waiting was based on a poor evi-
dence base, but in the late 1980s effectiveness studies
showed that TURPs offered the benefit of easier and
less frequent urination but with the tradeoff of much
higher rates of incontinence and sexual dysfunction
than previously appreciated by the medical community.
Most importantly, average patience preferences favored
less TURPs than were observed in utilization rates.
These average preferences hid the diversity of values
(i.e. utilities) assigned by patients and physicians to the
known outcomes. While the “best” choice was the deci-
sion that would maximize the utility for each patient,
most decisions rested on the average utility assigned by
the urologist. Examples of preference sensitive care
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include treatment options associated with early stage
prostate and breast cancer, lower back pain, and arthro-
plasty. Variation in treatment utilization rates for these
conditions reflects the local practice style of physicians,
which originates from training and then is molded by
clinical experience.
Unfortunately, physicians are poor at diagnosing patient
preferences [23]. Improving decision quality through
shared decision-making requires new methods of con-
veying information to patients, such as decision aids,
[24] accompanied by encouraging patient identification
of preferences and participation in the decision process.
Often, but not always, the introduction of decision aids
reduces utilization rates of procedures or aggressive
care. Unlike effective sensitive care, there is no single
“right rate.” The right rate for a population reflects the
average decisions of informed and engaged patients and
families. It is expected that the care choices may differ
across families, and in turn, across regions.
Variation in supply sensitive care
Supply sensitive care refers to medical services for which
utilization rates are responsive to the local availability of
health care capacity, such as beds and physicians [25].
These services have also been termed discretionary.
While in some instances a low supply of resources may
constrain effective care, this category is concerned with
the range of capacity that is viewed as adequate.
The backdrop to supply sensitive care is that the
regional variation in capacity in many countries does
not reflect differences in population need. Despite
some efforts to direct physicians, hospital beds, and
catheterization labs to places where health status is
lower, historical patterns of hospital building and phys-
ician location patterns tend to favor more affluent and
attractive communities [26, 27].
In the U.S., medical admissions for chronic illness are
considered supply sensitive care [28, 29]. Medical dis-
charge rates in the elderly vary 200–300% across hospital
services areas and are strongly influenced by area bed
supply [26]. How can this occur? Congestive heart failure
(CHF) hospitalizations are a useful example. A clinician
caring for a patient in the office or ER with signs of wors-
ening CHF has the option of initiating more aggressive
treatment with outpatient monitoringor hospitalization,
and will decide after considering physiologic parameters,
past medical history, and available family and patient pref-
erences. Clinical opinions regarding the “right choice” for
a specific patient can differ frequently, even for physicians
familiar with clinical guidelines. Invisible to the clinician is
the local supply of beds and its subtle influence on the
threshold of admission. As bed supply varies, so does
discharge rates for CHF along with most other medical
causes of admission. There is no evidence that U.S.
patients are harmed in regions with lower bed supply
and medical hospitalization rates, suggesting that there
are unrealized efficiency gains in reducing unnecessary
acute care [16, 17].
Further examples of supply sensitive care include the
number of hospital or ICU days for medical care, emer-
gency room visits, rates of consultations, physician revisit
rates, and imaging procedures. The decisions related to
these medical care events elude the concepts of efficacy
and effectiveness. Unlike effective care, population rate dif-
ferences are very weakly associated with outcomes [16, 17].
Israeli medical practice variation in context
Caution is needed in applying these ideas to Israel’s pat-
terns of care. The old adage comes to mind: if you’ve
seen one health care system, you’ve seen one health care
system. At the same time, the experiences from the U.S.
and from other OECD countries may identify future
directions for Israeli health policy research. Several
recommendations follow:
Measuring health across regions and providers re-
quires consistent efforts at improving measurement, and
encouraging inquiry by researchers and policy analysts.
Just as disease epidemiology continually monitors and
investigates health and disease, medical care epidemiology
requires a national commitment to using the findings
of population-based evidence to improve care. Israeli
patients would benefit from an expansion of health care
measures that are tabulated annually. Also, allowing re-
searchers access to the data would bring new insights
into the delivery of medical care.
Studies should incorporate more recent methods for
controlling for population differences to better reveal the
proportion of variation that is unwarranted [5]. The best
method is highly dependent on the specific research ques-
tion, the population of interest, and the quality of available
data. Applying improved methods of population adjust-
ment would increase the inferential value of the results.
Given the heterogeneity of both population and
health care delivery in Israel, further insight may be
gained by studies that use smaller areas or hospitals
as the units of analysis. Ideally, the scale of measure-
ment is dictated by the extent of regionalization of
care, ranging from primary care [30] to tertiary care
[31]. Hospital specific cohorts for conditions such as
acute myocardial infarctions or end of life cancer care
can provide high specificity and insight into the
responsible health care systems [32, 33].
Finally, without identifying the causes of unwarranted
variation, improvement efforts operate in the dark. As
descriptions of the Israeli health care utilization develop,
a national investment in research examining the causes
and consequences of variation is likely to have high
returns for patients.
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Conclusion
The strains in health care are increasingly evident. The
public expects continual gains in medical science, in the
development of prevention measures and illness treat-
ment, and in their equitable dissemination through an
ever more comprehensive health system. Care known to
have high benefits to patients is often incompletely im-
plemented. Low value care disguised as innovative treat-
ments frequently takes root, often at great expense and
potential harm. In some instances, patients remain in
the dark about available treatment options, as clinicians
make well-meaning recommendations that align poorly
with patient preferences. Worldwide, rising costs chal-
lenge the ability of the health care system to meet these
expectations as health care takes an increasing propor-
tion of national wealth, competing against needs in edu-
cation, housing, and other strategic investments. Israel
has successfully constrained spending as a proportion of
GDP, but the growth of private spending is high [34]. As
public expectations continue to rise in an era of limits in
public and private spending, measuring health system
performance and its variation across providers can guide
the search for better value in health care.
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